Loading clinical trials...
Loading clinical trials...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a life-saving treatment for many malignant hematologic diseases. Its curative potential is due to both high-dose chemotherapy and the ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT06510699 · Fungal Infection, Haematological Malignancy, and more
NCT05873205 · Blood Cancer, Refractory Immune Cytopenias
NCT07148180 · Acute Myeloid Leukaemia (AML), Leukemia, and more
NCT06455592 · Child, Only, Blood Cancer, and more
NCT06250595 · Anemia, Bone Marrow Failure, and more
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions